Lipopolysaccharide-binding protein in microbial invasion of the amniotic cavity and human parturition

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 12, Issue 5, 2002, Pages 313-321

  Espinoza, J ^a   Romero, R ^a,f   Chaiworapongsa, T ^a   Kim, J C ^a   Yoshimatsu, J ^a   Edwin, S ^a   Rathnasabapathy, C ^a   Tolosa, J ^b   Donnenfeld, A ^c   Craparo, F ^d   Gomez, R ^e   Bujold, E ^f  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d ABINGTON MEMORIAL HOSPITAL   (United States)

^e HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^f HUTZEL HOSPITAL   (United States)

Author keywords

Amniotic fluid; Chorioamnionitis; Endotoxin; Lipopolysaccharide binding protein; Preterm labor; Toll like receptor

Indexed keywords

LIPOPOLYSACCHARIDE BINDING PROTEIN;

AMNIOCENTESIS; AMNION; AMNIONITIS; ARTICLE; CHILDBIRTH; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LABOR; MAJOR CLINICAL STUDY; MICROBIAL CONTAMINATION; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER ABORTION;

EID: 0036854514     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.12.5.313.321     Document Type: Article

References (50)

1. Janeway C. Immunogenicity signals 1,2,3 . . . and 0. Immunol Today 1989;10:283-6
2. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1-13
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216
4. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300
5. Downey JS, Han J. Cellular activation mechanisms in septic shock. Front Biosci 1998;3:d468-76
6. Romero R, Mazor M, Wu YK, et al. Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids 1989;37:183-6
7. Romero R, Roslansky P, Oyarzun E, et al. Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol 1988;158:1044-9
8. Romero R, Hobbins JC, Mitchell MD. Endotoxin stimulates prostaglandin E2 production by human amnion. Obstet Gynecol 1988;71:227-8
9. Romero R, Kadar N, Hobbins JC, et al. Infection and labor: The detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 1987;157:815-19
10. Bennett WA, Terrone DA, Rinehart BK, et al. Intrauterine endotoxin infusion in rat pregnancy induces preterm delivery and increases placental prostaglandin F2alpha metabolite levels. Am J Obstet Gynecol 2000;182:1496-501
11. Schumann RR. Function oflipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: A short review. Res Immunol 1992;143:11-15
12. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function of lipopolysaccharide binding protein. Science 1990;249:1429-31
13. Schumann RR, Zweigner J. A novel acute-phase marker: Lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 1999;37:271-4
14. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986;164:777-93
15. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002;323:59-72
16. Jiang Q, Akashi S, Miyake K, et al. Lipopolysaccharide induces physical proximity between CD14 and toll-like rector 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541-4
17. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genet 2000;25:187-91
18. Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998;64:25-32
19. Schumann RR, Latz E. Lipopolysaccharide-binding protein. Chem Immunol 2000;74:42-60
20. Gardella C, Hitti J, Martin TR, et al. Amniotic fluid lipopolysaccharide-binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor. Am J Obstet Gynecol 2001;184:1241-8
21. Roos T, Martin TR, Ruzinski JT, et al. Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. Am J Obstet Gynecol 1997;177:1230-7
22. Romero R, Quintero R, Nores J, et al. Amniotic fluid white blood cell count: A rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991;165:821-30
23. Romero R, Avila C, Santhanam U, et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990;85:1392-400
24. Romero R, Manogue KR, Mitchell MD, et al. Infection and labor. IV. Cachectin-tumor necrosis factor m the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41
25. Romero R, Brody DT, Oyarzun E, et al. Infection and labor. III. Interleukin-1: A signal for the onset of parturition. Am J Obstet Gynecol 1989;160:1117-23
26. Santhanam U, Avila C, Romero R, et al. Cytokines in normal and abnormal parturition: Elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 1991;3:155-63
27. Romero R, Wu YK, Mazor M, et al. Amniotic fluid arachidonate lipoxygenase metabolites in preterm labor. Prostaglandins Leukot Essent Fatty Acids 1989;36:69-75
28. Romero R, Quintero R, Emamian M, et al. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1454-60
29. Heine RP, Wiesenfeld H, Mortimer L, et al. Amniotic fluid defensins: Potential markers of subclinical intrauterine infection. Clin Infect Dis 1998;27:513-18
30. Wenstrom KD, Andrews WW, Tamura T, et al. Elevated amniotic fluid interleukin-6 levels at genetic amniocentesis predict subsequent pregnancy loss. Am J Obstet Gynecol 1996;175:830-3
31. Romero R, Munoz H, Gomez R, et al. Two thirds of spontanous abortion/fetal deaths after genetic amniocentesis are the result of a pre-existing subclinical inflammatory process of the amniotic cavity. Am J Obstet Gynecol 1995;172:261 (abstr 24)
32. Donnenfeld A, Tolosa JE, Cohen J, et al. An elevated midtrimester amniotic fluid interleukin-6 soluble receptor level is a risk factor for subsequent fetal death. Am J Obstet Gynecol 1996;173:(abstr 453)
33. Gray DJ, Robinson HB, Malone J, et al. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111-17
34. Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: Potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294-302
35. Horowitz S, Mazor M, Romero R, et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the mid-trimester of pregnancy. J Reprod Med 1995;40:375-9
36. Yoon BH, Romero R, Park JS, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998;179:1254-60
37. Tobias PS, Mathison J, Mintz D, et al. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am J Respir Cell Mol Biol 1992;7:239-45
38. Gutsmann T, Muller M, Carroll SF, et al. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001;69:6942-50
39. Lamping N, Dettmer R, Schroder NW, et al. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998;101:2065-71
40. Jack RS, Fan X, Bernheiden M, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature (London) 1997;389:742-5
41. Kielian TL, Blecha F. CD14 and other recognition molecules for lipopolysaccharide: A review. Immunopharmacology 1995;29:187-205
42. Triantafilou K, Triantafilou M, Dedrick RL. Interactions of bacterial lipopolysaccharide and peptidoglycan with a 70 kDa and an 80 kDa protein on the cell surface of CD14+ and CD14 - Cells. Hum Immunol 2001;62:50-63
43. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-52
44. Troelstra A, Giepmans BN, Van Kessel KP, et al. Dual effects of soluble CD14 on LPS priming of neutrophils. J Leukoc Biol 1997;61:173-8
45. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109:707-12
46. Grunfeld C, Marshall M, Shigenaga JK, et al. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res 1999;40:245-52
47. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998;273:8680-90
48. Le Roy D, Di Padova F, Adachi Y, et al. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001;167:2759-65
49. Hubacek JA, Stuber F, Frohlich D, et al. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis. Crit Care Med 2001;29:557-61
50. Dorman T, Faraday N. Do gene variants really explain the heterogeneous outcomes in sepsis? Crit Care Med 2001;29:684-5